Clinical trial
Estrogen Receptor Variants, HDL, and Atherosclerosis
NCT00081705 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00081705 |
|---|---|
| Title | Estrogen Receptor Variants, HDL, and Atherosclerosis |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Atherosclerosis, Coronary Arteriosclerosis, Heart Diseases |
| Start date | Mar 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Apr 21, 2004 |
| Last update posted | Jul 29, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: